Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 21, 2023

BUY
$36.12 - $41.79 $3,070 - $3,552
85 Added 1.18%
7,291 $267,000
Q1 2023

May 05, 2023

BUY
$39.39 - $51.28 $4,135 - $5,384
105 Added 1.48%
7,206 $294,000
Q4 2022

Jan 30, 2023

BUY
$41.75 - $54.5 $2,588 - $3,379
62 Added 0.88%
7,101 $363,000
Q3 2022

Oct 24, 2022

SELL
$43.76 - $53.42 $61,964 - $75,642
-1,416 Reduced 16.75%
7,039 $316,000
Q2 2022

Jul 29, 2022

SELL
$46.53 - $55.17 $1,954 - $2,317
-42 Reduced 0.49%
8,455 $443,000
Q1 2022

May 06, 2022

BUY
$45.75 - $56.69 $175,359 - $217,292
3,833 Added 82.18%
8,497 $439,000
Q4 2021

Jan 27, 2022

BUY
$41.32 - $61.25 $192,716 - $285,670
4,664 New
4,664 $275,000
Q1 2021

Apr 23, 2021

SELL
$33.49 - $37.77 $622,679 - $702,257
-18,593 Closed
0 $0
Q4 2020

Feb 01, 2021

BUY
$33.47 - $42.56 $25,671 - $32,643
767 Added 4.3%
18,593 $684,000
Q3 2020

Oct 23, 2020

SELL
$31.75 - $37.25 $6,159 - $7,226
-194 Reduced 1.08%
17,826 $654,000
Q2 2020

Aug 03, 2020

SELL
$30.12 - $36.54 $10,361 - $12,569
-344 Reduced 1.87%
18,020 $589,000
Q1 2020

May 01, 2020

SELL
$27.03 - $38.62 $2,324 - $3,321
-86 Reduced 0.47%
18,364 $599,000
Q4 2019

Feb 10, 2020

BUY
$32.92 - $37.36 $3,028 - $3,437
92 Added 0.5%
18,450 $722,000
Q3 2019

Nov 04, 2019

BUY
$32.49 - $42.13 $13,385 - $17,357
412 Added 2.3%
18,358 $659,000
Q2 2019

Aug 13, 2019

BUY
$36.98 - $41.52 $8,246 - $9,258
223 Added 1.26%
17,946 $777,000
Q1 2019

May 08, 2019

BUY
$37.5 - $41.2 $77,400 - $85,036
2,064 Added 13.18%
17,723 $753,000
Q4 2018

Feb 14, 2019

BUY
$38.47 - $43.86 $602,401 - $686,803
15,659 New
15,659 $684,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Bernardo Wealth Planning LLC Portfolio

Follow Bernardo Wealth Planning LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bernardo Wealth Planning LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bernardo Wealth Planning LLC with notifications on news.